BioMarin Pharmaceutical Inc <BMRN.O>: Canaccord Genuity raises target price to $114 from $111
BMRN•Related News
Arc Group Acquisition I to buy Malaysia lender Firstborn Top Capital in deal valued at $1.09 billion
ARCL•
Bridgewater Bancshares director Douglas J. Parish disposes of 4,000 common shares for $85,536
BWB•
Portuguese group D3 sues Meta, TikTok and YouTube over addictive design
META•
Preferred Bank outlines franchise overview, financial metrics in investor presentation
PFBC•
Fortrea grants CFO Jason Knoblauch 106,755 PSUs and 144,434 RSUs as inducement awards
FTRE•